| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |